Short Article
Younes Mahrach, Nadira Mourabi
Abstract
The interest shown in recent years for bacterial infections caused by multidrug-resistant bacteria (MDRB), in particular carbapenemase-producing enterobacteria (CPE), by the pharmaceutical companies in charge of therapy is still current. In fact, these infections are of clinical importance because they constitute a major public health risk due to the difficulty of their treatment. Many authors have been interested in evaluating infections of carbapenemase-producing bacteria under various aspects at the epidemiological, clinical or even therapeutic level in order to fight against them. To our knowledge, few studies report the epidemiological and molecular aspects of these infections in Morocco. Our work aims to establish the prevalence and study the strains of carbapenemase-producing enterobacteria (CPE) found in patients at the Mohamed V regional hospital in Tangier in northern Morocco.